Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer
Si-Hyun Lee, Hwang-Phill Kim, Jun-Kyu Kang, Sang-Hyun Song, Sae-Won Han, Tae-You Kim
Cancer Res Treat. 2017;49(4):1077-1087.   Published online 2017 Jan 25     DOI: https://doi.org/10.4143/crt.2016.301
Citations to this article as recorded by Crossref logo
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer
Chaofan He, Fuxin Huang, Kejia Zhang, Jun Wei, Ke Hu, Meng Liang
Journal of Ovarian Research.2021;[Epub]     CrossRef
The Emerging Impact of RNA Editing in Tumor Growth and Metastasis
Mehrdad Nasrollahzadehsabet, Javad Behroozi
Annals of Military and Health Sciences Research.2021;[Epub]     CrossRef
Noncanonical Functions and Cellular Dynamics of the Mammalian Signal Recognition Particle Components
Camilla Faoro, Sandro F. Ataide
Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
Quantifying RNA Editing in Deep Transcriptome Datasets
Claudio Lo Giudice, Domenico Alessandro Silvestris, Shalom Hillel Roth, Eli Eisenberg, Graziano Pesole, Angela Gallo, Ernesto Picardi
Frontiers in Genetics.2020;[Epub]     CrossRef

The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in vivo and in vitro

Yujie Liu, Qianying Ouyang, Zeen Sun, Jieqiong Tan, Weihua Huang, Jie Liu, Zhaoqian Liu, Honghao Zhou, Feiyue Zeng, Yingzi Liu
Cancer Management and Research.2020; Volume 12: 5119.     CrossRef
Non-Coding RNA Editing in Cancer Pathogenesis
Giulia Romano, Michela Saviana, Patricia Le, Howard Li, Lavender Micalo, Giovanni Nigita, Mario Acunzo, Patrick Nana-Sinkam
Cancers.2020; 12(7): 1845.     CrossRef
Automated Isoform Diversity Detector (AIDD): a pipeline for investigating transcriptome diversity of RNA-seq data
Noel-Marie Plonski, Emily Johnson, Madeline Frederick, Heather Mercer, Gail Fraizer, Richard Meindl, Gemma Casadesus, Helen Piontkivska
BMC Bioinformatics.2020;[Epub]     CrossRef
RNA editing alterations define manifestation of prion diseases
Eirini Kanata, Franc Llorens, Dimitra Dafou, Athanasios Dimitriadis, Katrin Thüne, Konstantinos Xanthopoulos, Nikolaos Bekas, Juan Carlos Espinosa, Matthias Schmitz, Alba Marín-Moreno, Vincenzo Capece, Orr Shormoni, Olivier Andréoletti, Stefan Bonn, Juan
Proceedings of the National Academy of Sciences.2019; 116(39): 19727.     CrossRef
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications
Elisa Porcellini, Noemi Laprovitera, Mattia Riefolo, Matteo Ravaioli, Ingrid Garajova, Manuela Ferracin
Cancer Letters.2018;[Epub]     CrossRef
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Jing Yuan Chooi, Sabrina H. M. Toh, Shuangyi Fan, Wilson Wang, Bryan T. H. Koh, Melissa J. Fullwood, Melissa G. Ooi, Sanjay de Mel, Cinnie Y. Soekojo, Leilei Chen, Siok Bian Ng, Henry Yang, Wee Joo Chng
Blood.2018; 132(12): 1304.     CrossRef
ADAR1 prevents small intestinal injury from inflammation in a murine model of sepsis
Shanshou Liu, Jiangang Xie, Bin Zhao, Xiaomin Hu, Xiao Li, Bin Zhang, Xianqi Wang, Yanjun Wang, Jinquan Jiang, Wen Yin, Junjie Li
Cytokine.2018; 104: 30.     CrossRef